Mark Emberton holds the positions of Professor of Interventional Oncology at UCL and Honorary Consultant Urologist at UCLH.
In April 2012, Mark was appointed Director to the Division of Surgery and Interventional Science. During this time, he has re-structured the Division into 3 broad research themes: Materials and Tissue; Tissue and Energy; and Nanotechnology. Each research theme look very much to the surgery of the future: where implants will interact or be replaced by the patient's own tissue; where beams of energy will replace surgeons' knives; and where organs will be engineered to order.
He leads an internationally recognised research group that looks to more accurate ways of diagnosing men with prostate cancer and treatments that are better tolerated and cause less harm. He is a major grant holder, a frequent speaker at international meetings and has published over 250 peer reviewed scientific papers.